Soligenix to present at the microcap conference

Princeton, n.j. , jan. 25, 2024 /prnewswire/ -- soligenix, inc. (nasdaq: sngx) (soligenix or the company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the company will deliver a corporate presentation at the microcap conference.

SNGX Ratings Summary

SNGX Quant Ranking